GlassScriptPhysician profile
Mark Lawrence Moody
NPI 1821173618
$4,045.44
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,393 · 2020: $370 · 2021: $627 · 2022: $386 · 2023: $948 · 2024: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,268.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $1,238.91 | 2019-2023 | Invictus Open |
| Si-Bone, INC. | $1,209.24 | 2019-2024 | |
| Medtronic, INC. | $585.19 | 2021-2024 | Mazor X System, Anatomic Peek Ptc Cervical Fusion System, Stealthstation S8 Platform |
| Medtronic USA, INC. | $210.21 | 2019-2020 | |
| Carlsmed, INC. | $181.72 | 2022 | |
| Intrinsic Therapeutics | $142.82 | 2023 | Barricaid Acd (Annular Closure Device) |
| Choice Spine, LLC | $132.26 | 2023 | Stratofuse, Blackhawk Cervical Spacer System, Harrier-Sa Lumbar Interbody System |
| Globus Medical, INC. | $111.69 | 2021 | |
| Spine Wave, INC. | $90.03 | 2023 | Spinal Implant |
| Abbott Laboratories | $57.45 | 2023-2024 | Proclaim, Penta |
| Providence Medical Technology, INC. | $48.55 | 2023 | |
| Peerless Surgical INC. | $22.49 | 2021 | |
| Spineology INC. | $14.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Moody listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.